Article

lock Open Access lock Peer-Reviewed

1

Views

SCHEDULE OF MEETINGS/SYMPOSIA AND MEETINGS

Cytokine activation (tumor necrosis factor - a) and clinical response induced by cardiopulmonary bypass

Luiz Antônio Brasil; Walter José Gomes; Reinaldo Salomão; Ênio Buffolo

DOI: 10.1590/S0102-76381996000300009

Full text available only in PDF format.

REFERENCES

1. Westaby S - Organ dysfunction after cardiopulmonary bypass: a systemic inflammatory reaction by the extracorporeal circuit. Intensive Care Med 1987; 13: 89-5.

2. Butler J, Chong G L, Baigrie R J, Pillai R, Westaby S, Rocher G M - Cytokine response to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53: 833-8. [MedLine]

3. Chenoweth D E, Cooper S W, Hugli T E, Stewart R W, Blackstone E H, Kirklin J W - Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxis. N Engl J Med 1981; 304: 497-503. [MedLine]

4. Kirklin J K, Westaby S, Blackstone E H, Kirklin J W, Chenoweth D E, Pacifico A D - Complement and the damaging effcts of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57. [MedLine]

5. Casey L C - Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993; 56: 92-6. [MedLine]

6. Steinberg B, Grossi E A, Scwartz D S et al. - Heparin bonding of bypass circuits reduces cytokine release during cardiopumonary bypass. Ann Thorac Surg 1995; 60: 525-9. [MedLine]

7. Jansen N J, Van Oeveren W, Gu Y J, Van Vliet M H, Eijsman L, Wildevuur C R - Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 744-8.

8. Andersen L W, Baek L, Degn H, Lehd J, Krasnik M, Rasmussen S P - Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987; 93: 115-9. [MedLine]

9. Rocke D A, Gaffin S L, Wells M T, Koen Y, Brock-Utine J G - Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 832-7. [MedLine]

10. Butler J, Rocher G M, Westaby S - Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-9. [MedLine]

11. Andersen L W, Landow L, Jansen E, Barker S - Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21:210-7. [MedLine]

12. Gomes W J, Carvalho A C, Palma J H, Gonçalves Jr. I, Buffolo E - Vasoplegia syndorme: a new dilemma. J Thorac Cardiovasc Surg 1994; 107: 942-3. [MedLine]

13. Haeffner-Cavaillon N, Rousselier N, Ponzio O - Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 1100-6. [MedLine]

14. Jansen N J, Van Oeveren W, Van Der Broek L et al. - Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991; 102:515-25. [MedLine]

15. Moat N E,Shore D F, Evans T W - Organ dysfcunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993; 7: 563-73. [MedLine]

16. Beutler B & Cerami A - Cachetin: more than a tumor necrosis factor. N Engl J Med 1987; 316: 379-85. [MedLine]

17. Beutler B & Cerami A - The common mediator of shock cachexia and tumor necrosis. Adv Immunol 1988; 42: 213-31. [MedLine]

18. Tracey K J, Fong Y, Hesse D G et al. - Anti-cachetin / TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 682-4.

19. Michie H R, Manogue K R, Spriggs D R et al. - Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988; 318: 1481-6. [MedLine]

20. Nathan C & Sporn M - Cytokines in context. J Cell Biol 1991; 113: 981-6. [MedLine]

21. Beutler B & Cerami A - Tumor necrosis, cachexia, shock and inflammation: a common mediator. Ann Rev Biochem 1988; 57: 505-18.

22. Beutler B - TNF in pathophysiology: biosynthetic regulation. J Invest Dermat 1990; 95 (Suppl.): 81-4.

23. Beutler B - The tumor necrosis factors: cachetin and lymphotoxin. Hosp Pract 1990; 15: 45-58.

24. Kutteh W H, Rainey W E, Beutler B, Carr B R - Tumor necrosis factor-alpha and interleukin-1 beta production by human fetal kupffer cell. Am J Obstet Gynecol 1991; 165: 112-20. [MedLine]

25. Djeu J Y, Blanchard D K, Richards A L, Friedman H - Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol 1988; 141: 4047-52. [MedLine]

26. Tracey K J, Vlassara H, Cerami A - Cachetin/tumor necrosis factor. Lancet 1989; 1: 1122-6. [MedLine]

27. Waage A, Halstensen A, Espevik T - Association between tumor necrosis factor and fatal outcome in patients with meningococcal disease. Lancet 1987; 14: 355-7.

28. Rothe J, Lesslauer W, Lotsher H et al. - Mice lacking the tumor necrosis factor receptor 1 are resistent to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993; 364: 798-802. [MedLine]

29. Aggarwal B B, Kohr B J, Hass P E et al. - Human tumor necrosis factor production, purification and characterization. J Biol Chem 1985; 260: 2345-54. [MedLine]

30. Beutler B, Milsark I W, Cerami A - Cachetin/Tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972-7. [MedLine]

31. Staubep G B, Aiyer R A, Aggarwall B B - Human tumor necrosis factor-alpha receptor: purification by immunoaffinity chromatografhy and initial characterization. J Biol Chem 1988; 263: 19098-104. [MedLine]

32. Flick D A & Gifford G E - Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 1984; 68: 167-75. [MedLine]

33. Santos B F C - Produção do fator de necrose de tumor por leucócitos mononucleares humanos [Tese. Mestrado] São Paulo: Escola Paulista de Medicina da Universidade Federal de São Paulo, 1992. 65p.

34. Karhawi A S K - Avaliação dos níveis plasmáticos de fator de necrose tumoral-alpha (TNF-alpha), interleucina-6 (IL-6) e contagem de linfócitos-T CD4+ e CD8+ em pacientes com paracoccidioidomícose [Tese. Mestrado] São Paulo: Escola Paulista de Medicina da Universidade Federal de São Paulo, 1994. 123p.

35. Rus H G, Niculescu F, Vlaicu R - Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1993; 89: 247-54.

36. Vaddi K, Nicolini F A, Metha P, Metha J L - Increased secretion of tumor necrosis factor-alpha and interferon gama by mononuclear leukocytes in patients with ischemic heart disease. Circulation 1994; 90: 694-9. [MedLine]

37. Casey W F, Hauser G J, Hanrallah R S, Midgley F M, Khan W N - Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med 1992; 20: 1090-6. [MedLine]

38. Holzheimer R G, Molloy R G, Gorlach H, Wilkert S, Herlein F - IL6 and TNF-alpha release in association with neutrophil activation after cardiopulmonary bypass surger. Infection 1994; 22: 37-42. [MedLine]

39. Kharazmi A, Andersen L W, Baek L, Valerius N H, Laub M, Rasmussen J P - Endotoxemia and enhanced generation of oxygen radicals by neuthophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 381-5. [MedLine]

40. Nilsson L, Kulander L, Nystrom S O, Eriksson O - Endotoxins in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 100: 777-80. [MedLine]

41. Andersen L W, Baek L, Thomsen B S - Effect of methylprednisolone on endotoxaemia and complement activation during cardiac surgery. J Cardiothorac Anesth 1989; 3: 544-9. [MedLine]

42. Martinez-Pellus A E, Merino P, Bru M, et al. - Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993; 21: 1684-91. [MedLine]

43. Beutler B, Mahoney J, Trang N L, Pekala P, Cerami A - Purification of cachectin a lipoprotein lipase-supressing hormone secreted by endotoxin-induced RAW 264.7 cells. J Exp Med 1985; 161: 984-95. [MedLine]

44. Fong Y, Moldawer L L, Shires G T, Lowry S F - The biologic characteristics of cytokines and their implications in surgical injury. Surg Gynecol Obstet 1990; 170: 363-78. [MedLine]

45. Carswell E A, Old L J, Kassel R L, Green S, Fiore N, Williamson B - An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-70.

46. Beutler B, Milsark I W, Cerami A - Passive immunization against cachetin / tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869-71. [MedLine]

47. Okusawa S, Yancey K B, Van Der Meer J W M - C5a stimulates secretion of tumor necrosis factor form human mononuclear in vitro: comparison with secretion of interleukin-1 beta and interleukin-1 alfa. J Exp Med 1988; 168: 443-8. [MedLine]

48. Casey L C, Balk R A, Bone R C - Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-8. [MedLine]

49. Hennein H A, Ebba H, Rodriguez J L et al. - Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac cardiovasc Surg 1994; 108: 626-35. [MedLine]

50. Lahat N, Zlotnick A Y, Shtiller R, Bar I, Merin G - Serum levels of IL-1, IL-6 and tumor necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89: 255-60. [MedLine]

51. Millar A B, Foley N M, Singer M, Johnson N M, Meager A, Rook G A W - Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989; 2: 712-4. [MedLine]

52. Markewitz A, Faist E, Lang S, Endres S, Hultner L, Reichart B - Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 1993; 55: 389-94. [MedLine]

53. Hill G E, Alonso E, Thiele G M, Robbins R A - Glucocorticoids blunt neutrophil CD11b surface glycoprotein impregnation during cardiopulmonary bypass in humans. Anesth Analg 1994; 79: 23-7. [MedLine]

54. Inaba H, Kochi A, Yorozu S - Suppression by methylprednisolone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass. Br J Anaesth 1994; 72: 348-50. [MedLine]

55. Journois D, Pouard P, Greeley W J, Mauriat P, Vouhe P, Safran D - Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Effects on hemostasis, cytokines and complement components. Anesthesiology 1994; 81: 1181-9.

56. Millar A B, Armstrong L, Van Der Linden J et al. - Cytokine production and hemofiltration in children undergoing cardiopulmanary bypass. Ann Thorac Surg 1993; 56: 1499-502. [MedLine]

57. Gu Y J, Van Oeveren W, Akkerman C, Boonstra P W, Huyzen R J, Wildevuur C R - Heparin-coated circuits reduce the inflamatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105: 234-41. [MedLine]

58. Lilly C M, Sandhu J S, Ishizaka A - Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 1989; 139: 1361-8. [MedLine]

59. Sullivan G W, Carper H T, Novick W J, Mandell G L - Inhibition of the inflamatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifyline. Infect Immunol 1988; 56: 1722-9.

60. Buffolo E, Gomes W J, Andrade J C S et al. - Revascularização miocárdica sem circulação extracorpórea: resultados cirúrgicos em 1090 pacientes. Arq Bras Cardiol 1994; 62: 149-53. [MedLine]

CCBY All scientific articles published at bjcvs.org are licensed under a Creative Commons license

Indexes

All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery DEVELOPMENT BY